Regadenoson injection
Products billed under this code include Regadenoson.
Payment limit per 0.1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under this code include Regadenoson.
Payment limit per 0.1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Regadenoson | GE Healthcare Inc. | 00407-5034-05 | 40 | $100.28 |
| Regadenoson | Pfizer Inc | 00409-1401-01 | 40 | $100.28 |
| Regadenoson | Astellas Pharma US, Inc. | 00469-6501-89 | 4 | $10.028 |
| Regadenoson | Hikma Pharmaceuticals USA Inc. | 00641-6253-01 | 4 | $10.028 |
| Regadenoson | Baxter Healthcare Corporation | 36000-0364-01 | 4 | $10.028 |
| Regadenoson | Dr. Reddy's Laboratories Inc. | 43598-0616-11 | 4 | $10.028 |
| Regadenoson | Eugia US LLC | 55150-0443-01 | 4 | $10.028 |
| Regadenoson | Apotex Corp | 60505-6116-00 | 4 | $10.028 |
| Regadenoson | Apotex Corp | 60505-6288-00 | 4 | $10.028 |
| Regadenoson | Mylan Institutional LLC | 67457-0994-05 | 4 | $10.028 |
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Regadenoson | Meitheal Pharmaceuticals Inc. | 71288-0201-85 | 4 | $10.028 |
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $2.507 | −$0.283 | 0.1 MG | Regadenoson injection | v1, posted September 17, 2026 |
| 3Q26 | $2.79 | −$0.112 | 0.1 MG | Regadenoson injection | v1, posted September 15, 2026 |
| 2Q26 | $2.902 | +$0.223 | 0.1 MG | Regadenoson injection | v1, posted September 15, 2026 |
| 1Q26 | $2.679 | −$0.339 | 0.1 MG | Regadenoson injection | v1, posted September 15, 2026 |
| 4Q25 | $3.018 | +$0.126 | 0.1 MG | Regadenoson injection | v1, posted September 8, 2026 |
| 3Q25 | $2.892 | −$1.519 | 0.1 MG | Regadenoson injection | v1, posted March 10, 2026 |
| 2Q25 | $4.411 | +$0.60 | 0.1 MG | Regadenoson injection | v1, posted March 10, 2026 |
| 1Q25 | $3.811 | +$0.931 | 0.1 MG | Regadenoson injection | v1, posted December 19, 2025 |
| 4Q24 | $2.88 | −$0.511 | 0.1 MG | Regadenoson injection | v1, posted June 11, 2025 |
| 3Q24 | $3.391 | −$3.66 | 0.1 MG | Regadenoson injection | v1, posted June 11, 2025 |
| 2Q24 | $7.051 | −$7.229 | 0.1 MG | Regadenoson injection | v1, posted March 11, 2025 |
| 1Q24 | $14.28 | −$20.482 | 0.1 MG | Regadenoson injection | v1, posted December 19, 2024 |
| 4Q23 | $34.762 | −$27.513 | 0.1 MG | Regadenoson injection | v1, posted October 10, 2024 |
| 3Q23 | $62.275 | +$0.284 | 0.1 MG | Regadenoson injection | v1, posted June 5, 2024 |
| 2Q23 | $61.991 | +$0.84 | 0.1 MG | Regadenoson injection | v1, posted February 23, 2024 |
| 1Q23 | $61.151 | −$0.194 | 0.1 MG | Regadenoson injection | v1, posted December 6, 2023 |
| 4Q22 | $61.345 | −$0.13 | 0.1 MG | Regadenoson injection | v1, posted June 22, 2023 |
| 3Q22 | $61.475 | −$0.029 | 0.1 MG | Regadenoson injection | v1, posted June 9, 2023 |
| 2Q22 | $61.504 | +$0.217 | 0.1 MG | Regadenoson injection | v1, posted December 14, 2022 |
| 1Q22 | $61.287 | +$1.589 | 0.1 MG | Regadenoson injection | v1, posted June 8, 2022 |
| 4Q21 | $59.698 | +$0.147 | 0.1 MG | Regadenoson injection | v1, posted June 2, 2022 |
| 3Q21 | $59.551 | +$0.239 | 0.1 MG | Regadenoson injection | v1, posted June 2, 2022 |
| 2Q21 | $59.312 | −$0.06 | 0.1 MG | Regadenoson injection | v1, posted March 1, 2022 |
| 1Q21 | $59.372 | – | 0.1 MG | Regadenoson injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.